About the course
New research shows that genetic variations continue to accrue throughout tumor development. Having the ability to conduct deep sequencing on the healthy and cancerous cells in a patient, at multiple stages of growth and treatment, has led to invaluable findings and new directions for analyses in the field.
This course explores the role of genomics in cancer diagnosis, prognosis and treatment. Providing a greater view of mutations through tumor profiling, more targeted and personalized health care can be administered and positively impact disease outcomes. Discover the latest research advancing the study of cancer and the power of genomics in medical decision making.
This course is an elective course in the Stanford Genetics and Genomics Certificate.
You Will Learn
- Assessments of hereditary risk through multi-gene panel screens
- Classifications of cancers by genomic differences
- Evolutions of cancer cells that cause treatment resistance
- New technologies for non-invasive analyses
- Spectrums and sub-types of cancer mutations
Time to Complete
You should expect to spend 10-18 hours to complete each course, depending on your familiarity with the topic.
For individual courses, we recommend that you designate 2-3 hours per week to watch video lectures and complete assignments in order to finish within 60 days.
Since the All-Access Plan allows you to access all courses for one year, you can determine how quickly to progress, but you must complete courses with 365 days in order to receive credit.
You can earn the Stanford Genetics and Genomics Certificate by successfully completing the two required and any four elective courses. You may enroll in courses individually or through the All-Access Plan.
Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University. He is a le...
The Curtis laboratory couples innovative experimental approaches, high-throughput omic technologies, statistical inference and computational modeling to interrogate the evolutionary dynamics of tumor progression and therapeutic resistance. To this end, Dr. Curtis and her team have developed an in...
Dr. Ford is a medical oncologist and geneticist at Stanford, devoted to studying the genetic basis of breast and GI cancer development, treatment and prevention. Dr. Ford graduated in 1984 Magna Cum Laude (Biology) from Yale University where he later received his M.D. degree from the School of Me...
Natalie is a Post-Doctoral Scientist in the laboratory of Professor Michael Snyder at Stanford University. Her duties include applying approaches comprising genome sequencing, transcriptomics, and proteomics to the analysis of human disease, to help understand the molecular basis of disease and a...
Lars Steinmetz studied molecular biophysics and biochemistry at Yale University and conducted his Ph.D. research on genome-wide approaches to study gene function and natural phenotypic diversity at Stanford University. After a brief period of postdoctoral research at the Stanford Genome Technolog...
Videos and materials
Because of COVID-19, many providers are cancelling or postponing in-person programs or providing online participation options.
We are happy to help you find a suitable online alternative.